Type 1 diabetes patients do not have amylin treatment and, therefore, have unphysiological postprandial glucagon secretion, fast gastric emptying, and impaired satiety signaling, all of which are factors that can contribute to glycemic variability, postprandial hyperglycemia, and weight gain in intensive insulin therapy
It is usually paired with food and stress work, since those inputs still drive the flare
The study showed that GLP-1RAs did not show increased melanoma risk (HR 0.96, 95% CI 0.531.75) or nonmelanoma skin cancer risk (HR 1.03, 95% CI 0.801.33) when compared to sulfonylureas
Im also noticing my morning blood sugar is more stable
With over 30 years of combined experience in evidence-based practices, these professionals view clients holistically, not just as diagnoses